Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
CMO & Global Therapeutics Lead
-
Stock Symbol
-
RVNC on Nasdaq
David Hollander - trading volume in the past year for Revance Therapeutics, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
105K |
$438K |
$4.17 |
Nov 18, 2024 |
Direct |
|
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.